Abstract

Objective It is sometimes difficult to obtain complete/partial response of large hepatocellular carcinoma (HCC) nodules by trans-arterial chemoembolization/embolization (TACE/TAE). The aim is retrospective investigation of tumor response of large HCC nodules (>7 cm) treated by the new TACE technique, repeated alternate infusion of cisplatin solution, and sparse gelatin slurry under balloon occlusion (RAIB-TACE). Materials and Methods. A microballoon catheter was placed at a proximal portion of the hepatic artery (subsegmental to the lobar level hepatic artery), and alternate infusion of cisplatin solution and sparse gelatin slurry were repeated under balloon occlusion until stasis of gelatin slurry beyond the catheter was seen. RAIB-TACE of multiple proximal hepatic and extrahepatic collateral arteries were performed to treat hemi-lobe or more of the liver while avoiding infusion into gastric and cystic arteries for 19 large nodules (>7 cm) in 19 patients without portal venous invasion. All patients underwent dynamic CT/MRI 1–3 months after RAIB-TACE, and tumor response of each large nodule was evaluated based on modified RECIST criteria. Results CR, PR, SD, and PD were achieved in 11, 8, 0, and 0 nodules, respectively. CR and PR were considered as success, and the ratio of success was 100%. Major complications were abscess formation in the necrotic nodule (n = 1) which was treated by drainage tube placement, and subsegmental level liver infarction (n = 1) which was treated by drainage tube placement, and subsegmental level liver infarction (Conclusion New TACE technique, RAIB-TACE, was useful to achieve successful response of large HCC nodules.

Highlights

  • Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. e role of trans-arterial chemoembolization (TACE) is to treat HCC when neither surgery nor radiofrequency ablation (RFA) is indicated [1].e HCC diameter is one of the main factors that determine TACE efficacy of the nodules [2]

  • Alternate infusion of cisplatin solution and sparse gelatin slurry was repeated via the trunk artery under balloon occlusion until stasis of gelatin slurry was seen beyond the catheter (RAIB-TACE) [8]

  • Between December 2014 and April 2018, a total of 19 large nodules (>7 cm) in 19 patients were treated by the RAIBTACE technique

Read more

Summary

Objective

It is sometimes difficult to obtain complete/partial response of large hepatocellular carcinoma (HCC) nodules by transarterial chemoembolization/embolization (TACE/TAE). e aim is retrospective investigation of tumor response of large HCC nodules (>7 cm) treated by the new TACE technique, repeated alternate infusion of cisplatin solution, and sparse gelatin slurry under balloon occlusion (RAIB-TACE). E aim is retrospective investigation of tumor response of large HCC nodules (>7 cm) treated by the new TACE technique, repeated alternate infusion of cisplatin solution, and sparse gelatin slurry under balloon occlusion (RAIB-TACE). A microballoon catheter was placed at a proximal portion of the hepatic artery (subsegmental to the lobar level hepatic artery), and alternate infusion of cisplatin solution and sparse gelatin slurry were repeated under balloon occlusion until stasis of gelatin slurry beyond the catheter was seen. RAIB-TACE of multiple proximal hepatic and extrahepatic collateral arteries were performed to treat hemi-lobe or more of the liver while avoiding infusion into gastric and cystic arteries for 19 large nodules (>7 cm) in 19 patients without portal venous invasion. New TACE technique, RAIB-TACE, was useful to achieve successful response of large HCC nodules

Introduction
Materials and Methods
Results
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call